Tumor metabolic reprogramming in lung cancer progression

Oncol Lett. 2022 Jun 28;24(2):287. doi: 10.3892/ol.2022.13407. eCollection 2022 Aug.

Abstract

Metabolic reprogramming is an important characteristic of tumor cells. Tumor cells reprogram their metabolic pathways to meet the material, energy and redox force needs for rapid proliferation. Metabolic reprogramming changes the level or type of specific metabolites inside and outside cells, and promotes tumor growth by affecting gene expression, cell state and the tumor microenvironment. Glucose metabolism, glutamine metabolism and lipid metabolism are significant metabolic pathways in tumors. Targeting metabolic reprogramming can significantly inhibit tumor growth and induce apoptosis. Metabolic reprogramming also plays an important role in maintaining the growth advantage of tumor cells and enhancing the chemotherapy tolerance of lung cancer. This review summarizes abnormal changes in the metabolism of glucose, fat and amino acids in lung cancer, and the underlying molecular mechanism, with the aim of providing novel ideas for the prevention, early diagnosis and treatment of lung cancer.

Keywords: lung cancer; metabolic reprogramming.

Publication types

  • Review

Grants and funding

This research was supported by a grant from the Scientific Research Program of Tianjin Education Commission (no. 2020KJ151).